Skip to main content
Equibles

Ricki Fairley

Board Member

Xeris Biopharma Holdings, Inc. (XERS)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Ricki Fairley

Ricki Fairley is recorded as Board Member at Xeris Biopharma Holdings, Inc. (XERS). Xeris Biopharma Holdings, Inc. reported in an 8-K filed March 28, 2025 that Ricki Fairley resigned as director, effective March 28, 2025. Xeris Biopharma Holdings, Inc. reported in an 8-K filed June 5, 2024 that Ricki Fairley was appointed Class III director, effective June 5, 2024. Xeris Biopharma Holdings, Inc. reported in an 8-K filed March 29, 2023 that Ricki Fairley was appointed Class III director, effective March 27, 2023.

“On March 28, 2025, Ms. Ricki Fairley, a director of Xeris Biopharma Holdings, Inc. (the "Company"), notified the Company of her decision to resign from the Board of Directors (the "Board") of the Company, effective as of March 28, 2025.”
Xeris Biopharma Holdings, Inc. Form 8-K, filed March 28, 2025 · Read the filing
“to elect Paul R. Edick, Ricki Fairley and Marla S. Persky as Class III directors of the Company to serve until the 2027 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal ("Proposal 1")”
Xeris Biopharma Holdings, Inc. Form 8-K, filed June 5, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Xeris Biopharma Holdings, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.